Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin vs Marvelon for Cycle Control in Healthy Chinese Women
NCT00185419Phase 3Completed
- Sponsor
- Bayer
- Start
- Nov 2003
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of drospirenone in pregnancy (2 arms), sponsored by Bayer. Primary endpoint: Cycle control (unexpected intracyclic bleeding). Started Nov 2003; status: completed.
02
Drugs
drospirenone
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT00185419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185419.